Larimar Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 21.23 M | $82.17 M | 0.00% | 33.28% |
JANUS HENDERSON GROUP PLC | 02/14/2025 | 6.44 M | $24.94 M | 15.74% | 10.10% |
RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 6.05 M | $23.40 M | 0.00% | 9.47% |
BLUE OWL CAPITAL HOLDINGS LP | 02/14/2025 | 4.65 M | $18.01 M | 11.67% | 7.29% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 4.15 M | $16.07 M | -2.29% | 6.51% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 3.27 M | $12.64 M | 9.85% | 5.12% |
VANGUARD GROUP INC | 02/11/2025 | 2.19 M | $8.49 M | -4.54% | 3.44% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 2.10 M | $8.13 M | 23.47% | 3.29% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.27 M | $4.91 M | -0.72% | 1.99% |
VERITION FUND MANAGEMENT LLC | 02/14/2025 | 1.04 M | $4.02 M | -10.67% | 1.63% |
ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 984,077 | $3.81 M | 38.57% | 1.54% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 886,414 | $3.43 M | -1.65% | 1.39% |
MANGROVE PARTNERS | 02/14/2025 | 770,233 | $2.98 M | -10.00% | 1.21% |
FRED ALGER MANAGEMENT, LLC | 02/14/2025 | 737,553 | $2.85 M | -6.23% | 1.16% |
WOODLINE PARTNERS LP | 02/14/2025 | 622,682 | $2.41 M | -49.97% | 0.98% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 513,542 | $1.99 M | 45.13% | 0.80% |
ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 505,000 | $1.95 M | -27.13% | 0.79% |
SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 455,604 | $1.76 M | 9.92% | 0.71% |
ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 396,000 | $1.53 M | 102.04% | 0.62% |
DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 371,434 | $1.44 M | -24.85% | 0.58% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 254,947 | $986,645 | -66.62% | 0.40% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 233,873 | $905,087 | 278.79% | 0.37% |
ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 219,987 | $851,350 | -2.86% | 0.34% |
UBS OCONNOR LLC | 02/14/2025 | 188,543 | $729,661 | -7.02% | 0.30% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 174,788 | $676,430 | 0.00% | 0.27% |
GSA CAPITAL PARTNERS LLP | 02/07/2025 | 148,533 | $575,000 | 38.29% | 0.23% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 125,127 | $484,241 | 0.00% | 0.20% |
TREXQUANT INVESTMENT LP | 02/12/2025 | 123,066 | $476,265 | -18.56% | 0.19% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 116,067 | $449,179 | 10.28% | 0.18% |
MARSHALL WACE, LLP | 02/13/2025 | 110,304 | $426,876 | 52.16% | 0.17% |
JUMP FINANCIAL, LLC | 02/13/2025 | 107,544 | $416,195 | 13.62% | 0.17% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 100,453 | $388,754 | 1.85% | 0.16% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 85,788 | $332,000 | -28.22% | 0.13% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 81,150 | $314,051 | -24.09% | 0.13% |
BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 79,496 | $307,650 | 100.00% | 0.12% |
BARCLAYS PLC | 02/13/2025 | 70,425 | $273,000 | 17.31% | 0.11% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 67,579 | $261,531 | 224.01% | 0.11% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 67,024 | $259,383 | -30.99% | 0.11% |
XTX TOPCO LTD | 02/13/2025 | 63,810 | $246,945 | 316.27% | 0.10% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 58,526 | $226,496 | 0.00% | 0.09% |
STATE OF WISCONSIN INVESTMENT BOARD | 02/14/2025 | 57,958 | $224,297 | 46.41% | 0.09% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 56,294 | $217,858 | 32.76% | 0.09% |
RHUMBLINE ADVISERS | 01/30/2025 | 56,200 | $217,486 | 0.93% | 0.09% |
ENTRYPOINT CAPITAL, LLC | 02/11/2025 | 54,281 | $210,067 | 197.66% | 0.09% |
UBS GROUP AG | 02/14/2025 | 53,131 | $205,617 | 167.34% | 0.08% |
ALPS ADVISORS INC | 02/13/2025 | 51,590 | $199,653 | 100.00% | 0.08% |
02/10/2025 | 47,100 | $182,277 | 100.00% | 0.07% | |
FMR LLC | 02/13/2025 | 44,203 | $171,066 | -91.61% | 0.07% |
DEUTSCHE BANK AG\ | 02/14/2025 | 44,052 | $170,481 | -84.38% | 0.07% |
CITIGROUP INC | 02/12/2025 | 35,675 | $138,062 | 17.52% | 0.06% |
Larimar Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 140 institutional investors and hedge funds held shares of Larimar Therapeutics, Inc.. The most heavily invested institutionals were:
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 21.23 M
JANUS HENDERSON GROUP PLC: 6.44 M
RA CAPITAL MANAGEMENT, L.P.: 6.05 M
Blue Owl Capital Holdings LP: 4.65 M
GOLDMAN SACHS GROUP INC: 4.15 M
BlackRock Funding, Inc. /DE: 3.27 M
99.41% of Larimar Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 69.25 M shares in the last 24 months. This purchase volume represents approximately $274.21 M in transactions.